Anamorelin
Anamorelin (INN) (developmental code names ONO-7643, RC-1291, ST-1291), also known as anamorelin hydrochloride (USAN, JAN), is a non-peptide, orally-active, centrally-penetrant, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) with appetite-enhancing and anabolic effects which is under development by Helsinn Therapeutics for the treatment of cancer cachexia and anorexia.
primaryTopic
Anamorelin
Anamorelin (INN) (developmental code names ONO-7643, RC-1291, ST-1291), also known as anamorelin hydrochloride (USAN, JAN), is a non-peptide, orally-active, centrally-penetrant, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) with appetite-enhancing and anabolic effects which is under development by Helsinn Therapeutics for the treatment of cancer cachexia and anorexia.
has abstract
Anamorelin (INN) (developmenta ...... the European Medicines Agency.
@en
ATC prefix
CAS number
249921-19-5
IUPAC name
2-Amino-N-[(2R)-1-[(3R)-3-benz ...... opan-2-yl]-2-methylpropanamide
@en
PubChem
thumbnail
Wikipage page ID
46,947,408
Wikipage revision ID
743,970,459
ChemSpiderID
elimination half-life
molecular weight
5.4670358e+2
routes of administration
StdInChIKey
VQPFSIRUEPQQPP-MXBOTTGLSA-N
subject
comment
Anamorelin (INN) (developmenta ...... cancer cachexia and anorexia.
@en
label
Anamorelin
@en